Novozymes: all financial targets met or exceeded
date:Jan 22, 2014
expected financial impact from The BioAg Alliance with Monsanto. The BioAg Alliance does not affect the outlook for organic sales growth, but is expected to have a negative impact on sales growth in LCY and DKK of up to one percentage point. The BioAg Alliance is expected to have a positive impact on the EBIT margin of between a half and a full percentage point. All in all, including The BioAg Alliance, Novozymes expects organic and LCY sales growth of 6-9%, sales growth in DKK of 4-7%, EBIT gr
2/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/26 15:01